Login / Register

SBI Healthcare Opp Fund(G)-Direct Plan

very highequitypharma & health care
468.45 -8.53(-1.79%) NAV as on 13 Nov 2024
-2.41 % 1 M
45.6 % 1 Y
22.63 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

SCHEME DETAILS

Expenses Ratio :

1.95

As on 31 Oct, 2024
Age :

11 yrs 10 m

Since 01 01 ,2013
Exit Load :

0.5%

AUM :

3,416.13 Crs

Lock-in :

0.50% on or before 15D, Nil after 15D

Investing Style :

Large Growth

Portfolio Price To Book Value :

8.64

Min. Investment :

SIP 500 & Lumpsum 5000

Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund Manager :

Tanmaya Desai,Pradeep Kesavan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Oct 31 ,2024
Others 3.26 %
Equity 96.74 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.99 %
Max Healthcare Institute Ltd.6.26 %
Divi's Laboratories Ltd.6.21 %
Poly Medicure Ltd.5.38 %
Lupin Ltd.5.12 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs57.84
Hospital & Healthcare Services25.47
Medical Equipment/Supplies/Accessories5.38
Chemicals3.50
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)122.92213.53244.90242.72387.49
Net Assets(Rs Crores) (as on 31-Mar-2024) 853.49 1563.95 1778.29 1589.27 2626.34
Scheme Returns(%)(Absolute)-4.8575.4713.71-0.8160.57
B'mark Returns(%)(Absolute)NANANANANA
Category Rank13/7539/7548/7557/7614/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

SBI Healthcare Opp Fund-Reg(G)Very HighEquity411.97-7.52(-1.79%)NAV As on 13 Nov, 202414-Jul-1999Inception Date3,416.13AUM In Cr.45.60%1Y22.63%3Y29.13%5Y16.55%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.44-0.66(-1.73%)NAV As on 13 Nov, 202413-Jul-2018Inception Date5,024.00AUM In Cr.50.54%1Y22.19%3Y30.41%5Y23.14%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.49-0.40(-1.35%)NAV As on 13 Nov, 202428-Dec-2015Inception Date1,208.05AUM In Cr.41.76%1Y19.29%3Y27.01%5Y12.94%Since Inception
Nippon India Pharma Fund(G)Very HighEquity497.48-8.68(-1.71%)NAV As on 13 Nov, 202405-Jun-2004Inception Date8,688.65AUM In Cr.37.91%1Y18.21%3Y27.72%5Y21.05%Since Inception
Locate Us